A
Assertive Research Center, LLC | Assertive Research Center, LLC
Research site
Site insights
Top conditions
Top treatments
KarXT
CVL-865
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Bashar Mohsen
Verified by this site
Active trials
3 of 3 total trials
This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequ...
Enrolling
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules
Drug: Placebo
This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive...
Enrolling
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules
The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizur...
Active, not recruiting
Seizures
Drug: CVL-865
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems